Literature DB >> 11079016

Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis).

L J Layfield1, A Meloni-Ehrig, K Liu, R Shepard, J M Harrelson.   

Abstract

CONTEXT: Pigmented villonodular synovitis (PVNS) is a well-recognized entity that has the potential for extensive local destruction, even though it rarely metastasizes. Rare reports of malignant forms are recorded in the literature. We observed 2 patients in whom examples of PVNS followed an aggressive course with multiple recurrences, metastasis, or degeneration to an appearance resembling malignant fibrous histiocytoma.
OBJECTIVE: We studied the occurrence and persistence of aneuploidy for chromosomes 5 and 7 in 2 patients with clinically aggressive PVNS.
DESIGN: Fluorescence in situ hybridization was performed for the detection of chromosomes 5 and 7 in the primary lesions, recurrences, and metastases in 2 examples of PVNS.
RESULTS: Fluorescence in situ hybridization demonstrated small but significant numbers of cells with trisomies for chromosomes 7 and/or 5 in both the primary and recurrent lesions of both patients.
CONCLUSIONS: The presence of consistent chromosomal trisomies (5 and 7) in both patients' examples of PVNS suggests a neoplastic nature for this lesion. The persistence of these trisomies in the primary lesions, recurrences, and metastases supports a molecular link between the primaries, recurrences, and metastases despite changes in morphologic features. The presence of persistent trisomies in the recurrent and metastatic lesions supports the concept of malignant PVNS.

Entities:  

Mesh:

Year:  2000        PMID: 11079016     DOI: 10.5858/2000-124-1636-MGCTOS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  19 in total

Review 1.  MR findings of synovial disease in children and young adults: Part 1.

Authors:  Hee Kyung Kim; Andrew M Zbojniewicz; Arnold C Merrow; Jung-Eun Cheon; In-One Kim; Kathleen H Emery
Journal:  Pediatr Radiol       Date:  2011-02-22

2.  [Tenosynovial giant cell tumor].

Authors:  C Kuhnen; K-M Müller; S Rabstein; A Kasprzynski; P Herter
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

3.  A rare case of localised pigmented villonodular synovitis in the knee of a 24-year-old female soccer player: diagnosis, management and summary of tenosynovial giant cell tumours.

Authors:  Casper Falster; Simon Stockmann Poulsen; Uffe Joergensen
Journal:  BMJ Case Rep       Date:  2017-10-04

4.  Diffuse-type giant cell tumor of the subcutaneous thigh.

Authors:  D A Sanghvi; N C Purandare; N A Jambhekar; M G Agarwal; A Agarwal
Journal:  Skeletal Radiol       Date:  2006-03-25       Impact factor: 2.199

5.  Malignant giant cell tumor in the carpal tunnel: a case report and review of literature.

Authors:  Carla I J M Theunissen; Johannes Bras; Krijn P van Lienden; Miryam C Obdeijn
Journal:  J Wrist Surg       Date:  2013-08

6.  Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.

Authors:  Hongwei Cheng; Paul W Clarkson; Dongxia Gao; Marina Pacheco; Yuzhuo Wang; Torsten O Nielsen
Journal:  Sarcoma       Date:  2010-10-13

7.  Recurrent temporal bone tenosynovial giant cell tumor with chondroid metaplasia: the use of imaging to assess recurrence.

Authors:  Sofia Pina; Maria Fernandez; Silvia Maya; Roberto A Garcia; Ali Noor; Puneet S Pawha; Peter M Som
Journal:  Neuroradiol J       Date:  2014-02-24

Review 8.  MRI of Hoffa's fat pad.

Authors:  D Saddik; E G McNally; M Richardson
Journal:  Skeletal Radiol       Date:  2004-06-19       Impact factor: 2.199

9.  Pediatric giant cell tumor of the tendon sheath of the craniocervical junction involving the occipital condyle.

Authors:  Jin Mo Cho; Jong Hee Chang; Sun Ho Kim; Kyu Sung Lee
Journal:  Childs Nerv Syst       Date:  2015-07-26       Impact factor: 1.475

10.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.